Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Finance
Single-Use Bioreactors for Pharma: World Market 2013-2023

Global single-use bioreactors market: $76.5 million industry by 2017


Print article Print article
© companiesandmarkets.com

companiesandmarkets.com
companiesandmarkets.com
2014-03-14 16:53:01 - Single-Use Bioreactors for Pharma: World Market 2013-2023 - a new market research report on companiesandmarkets.com

The global single-use bioreactors market will reach $76.5m in 2017, and expand further to 2023. In recent years, single-use bioprocess technologies have greatly facilitated the development and production of biopharmaceuticals. Disposable components are being increasingly used in early biopharma development and upstream processing, as well as in commercial applications.

Overall revenues from the technologies will show strong growth from 2013 to 2023, with many commercial opportunities arising. Single-use technologies (bioprocess disposables) are becoming more important in the development and production of biopharmaceuticals. There will be a shift away from traditional biomanufacturing systems as newer, more-expedient disposable systems reach the biopharma industry from 2013 onwards.

Most experts agree that single-use equipment will become widely available for end-to-end bioprocessing across all production scales. Estimates

 

 

suggest that 50% of cGMP biomanufacturing already uses integrated disposable technologies. That trend will continue as single-use concepts mature, become robust and repeatable and prove their cost-effectiveness, especially for downstream operations.

For single-use bioreactors, the industry expects a transition from manual to automated, smart single-use bioreactor systems having feed based on real-time in-situ measurements. Scale is no longer an issue; disposable bioreactors of 2000L capacity and higher volumes are available to pharma companies. Biopharmaceutical producers seek to operate multiple (500-2000L) batches. Availability of high titres permits this and also reduces the risk of batch loss for manufacturers. Those trends make single-use bioreactors important for bioprocessing and cGMP operations.

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com